Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
08/03/2000 | CA2360683A1 Antidepressant heterocyclic compounds |
08/02/2000 | EP1024140A1 Process for N-alkylation of cyclic cyanoamidines |
08/02/2000 | EP1024138A1 Pyrazole derivatives |
08/02/2000 | EP1023265A1 Azetidinone derivatives for the treatment of hcmv infections |
08/02/2000 | EP1023068A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
08/02/2000 | EP1023057A1 Use of thiazolidinediones for the treatment of hyperglycaemia |
08/02/2000 | EP1023056A1 Use of thiazolidinediones for the treatment of hyperglycaemia |
08/02/2000 | CN1261889A Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agent |
08/02/2000 | CN1261881A 6-azauracil derivatives as IL-5 inhibitors |
08/01/2000 | US6096904 Discodermolides |
08/01/2000 | US6096898 One pot synthesis of 1,2,4-triazoles |
08/01/2000 | US6096895 Heterocyclic dihydrazole compounds and their use for controlling fungal plant diseases |
08/01/2000 | US6096887 Certain fused pyrrolecarboxamides; a new class of GABA brain receptor ligands |
08/01/2000 | US6096840 Gas phase polymerization process |
08/01/2000 | US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding |
08/01/2000 | US6096767 Muscarinic receptor agonists |
08/01/2000 | US6096763 Administering to the patients a2-oxo-1-benzimidazolinyl)piperidin-1-yl)alkyl)-1,2benzisothia zol-3-(2h)-one derivative as alpha-1a adrenergic receptor antagonist |
08/01/2000 | US6096754 N-3 substituted pyrimidin-4-ones with AII antagonistic activity |
08/01/2000 | US6096751 Substituted 1,2,3,4-tetrahydro-55-nitro-pyrimidines |
08/01/2000 | US6096736 Benzazepine derivatives with vasopressin agonistic activity |
08/01/2000 | US6096735 Benzoheterocyclic derivatives |
08/01/2000 | US6096689 5-pyrazolylbenzoic acid derivatives as herbicides |
07/27/2000 | WO2000043535A2 Composition and device for detecting leukocytes in urine |
07/27/2000 | WO2000043391A1 Substituted 1-(pieridin-4-yl)-3-(aryl) isothioureas their preparation and therapeutic application |
07/27/2000 | WO2000043388A1 Cationic methylenedioxy benzenes, their use for oxidation dyeing of keratin fibres, dyeing compositions and methods |
07/27/2000 | WO2000043387A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them |
07/27/2000 | WO2000043384A1 Aromatic heterocyclic compounds as antiinflammatory agents |
07/27/2000 | WO2000043377A1 Herbicidal oxadiazolidines |
07/27/2000 | WO2000043373A2 Kinase inhibitors |
07/27/2000 | WO2000043013A1 Pharmaceutical compositions for alleviating discomfort |
07/27/2000 | WO2000042868A1 Infant formula |
07/27/2000 | WO2000027832A3 Thiazole derivatives as ppar gamma ligands |
07/27/2000 | WO2000018767A3 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
07/27/2000 | WO2000003743A9 Use of inhibitors of prenyltransferases for inhibiting fungal growth |
07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
07/27/2000 | WO1999062881A8 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
07/27/2000 | CA2627837A1 Pharmaceutical compositions for alleviating discomfort |
07/27/2000 | CA2359689A1 Composition and device for detecting leukocytes in urine |
07/27/2000 | CA2359680A1 Kinase inhibitors |
07/27/2000 | CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
07/27/2000 | CA2359108A1 Herbicidal oxadiazolidines |
07/27/2000 | CA2359107A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them |
07/27/2000 | CA2359103A1 Substituted 1-(pieridin-4-yl)-3-(aryl) isothioureas their preparation and therapeutic application |
07/27/2000 | CA2322990A1 Cationic methylenedioxy benzenes, their use for oxidation dyeing of keratin fibres, dyeing compositions and methods |
07/26/2000 | EP1022274A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use |
07/26/2000 | EP1022272A1 Substituted fused heterocyclic compounds |
07/26/2000 | EP1022270A1 Pyrazole derivatives |
07/26/2000 | EP1022267A2 Process for the manufacture of diazonium compounds with a low sodium ions content |
07/26/2000 | EP1021429A1 Aryl furan derivatives as pde iv inhibitors |
07/26/2000 | EP1021424A1 Thiadiazole amide mmp inhibitors |
07/26/2000 | EP1021423A1 MACROCYCLIC INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF$g(a) SECRETION |
07/26/2000 | EP1021411A1 Benzamide derivatives as thrombin inhibitors |
07/26/2000 | EP1021410A1 Prostaglandin agonists and their use to treat bone disorders |
07/26/2000 | EP1021405A1 Azetidinone derivatives for the treatment of hcmv infections |
07/26/2000 | EP1021190A1 Novel amide derivatives |
07/26/2000 | EP0694032B1 Method for preparing beta-lactams |
07/26/2000 | CN1261370A Method of producing tiazofurin and other C-nucleosides |
07/26/2000 | CN1261364A Angiogenesis inhibiting thiadiazolyl pyridazine derivatives |
07/26/2000 | CN1261358A Angiogenesis inhiting 5-substituted-1,2,4-thiadiazolyl derivatives |
07/26/2000 | CN1261356A Substituted aminobeterocyclylamides |
07/26/2000 | CN1261276A Protease inhibitors |
07/25/2000 | US6093821 Process for preparing steroid receptor modulator compounds |
07/25/2000 | US6093737 2-oxo-piperidine substituted imidazole derivatives |
07/25/2000 | US6093736 Antibacterial agents |
07/25/2000 | US6093735 Selective β-3 adrenergic agonists |
07/25/2000 | US6093734 Pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs having a hydrolyzable sulfinyl or arylsulfonyl group attached to the benzimidazole nitrogen; gastrointestinal disorders |
07/25/2000 | US6093732 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
07/25/2000 | US6093716 Substituted 2-pyrimidineamines and processes for their preparation |
07/25/2000 | CA2197086C (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
07/25/2000 | CA2031463C Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them |
07/20/2000 | WO2000042038A1 Triazole compounds with dopamine-d3-receptor affinity |
07/20/2000 | WO2000042037A1 Triazole compounds with dopamine-d3-receptor affinity |
07/20/2000 | WO2000042036A1 Triazole compounds with dopamine-d3-receptor affinity |
07/20/2000 | WO2000042035A1 4-(heterocyclylsulfonamido) -5-methoxy-6- (2-methoxyphenoxy) -2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
07/20/2000 | WO2000042032A1 Substituted 2-imino thiazolines |
07/20/2000 | WO2000042031A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
07/20/2000 | WO2000042026A1 Non-peptide glp-1 agonists |
07/20/2000 | WO2000042023A1 Substituted imidazoles, their preparation and use |
07/20/2000 | WO2000041697A1 Utilisation of 2-substituted 1,2-benzisothiazole derivatives and 3-substituted tetrahydropyridopyrimidinone derivatives for the prophylaxis and therapy of cerebral ischaemia |
07/20/2000 | WO2000029406A3 Novel isoxazoline fibrinogen receptor antagonists |
07/20/2000 | CA2359952A1 Triazole compounds with dopamine-d3-receptor affinity |
07/20/2000 | CA2359942A1 Triazole compounds with dopamine-d3-receptor affinity |
07/20/2000 | CA2359562A1 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
07/20/2000 | CA2359390A1 Utilisation of 2-substituted 1,2-benzisothiazole derivatives and 3-substituted tetrahydropyridopyrimidinone derivatives for the prophylaxis and therapy of cerebral ischaemia |
07/20/2000 | CA2296173A1 A process for the production of diazonium compounds with a low content of sodium ions |
07/20/2000 | CA2296128A1 A process for the production of diazonium compounds with a low content of sodium ions |
07/19/2000 | EP1020445A1 Fused pyridine derivatives |
07/19/2000 | EP1019399A1 Aryl thiophene derivatives as pde iv inhibitors |
07/19/2000 | EP1019389A2 Epothilone derivatives |
07/19/2000 | EP1019387A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
07/19/2000 | EP1019386A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
07/19/2000 | EP1019385A1 Aminoaryl oxazolidinone n-oxides |
07/19/2000 | EP1019378A1 Hypoglycemic and hypolipidemic compounds |
07/19/2000 | EP1019373A1 Novel human nk 3? receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
07/19/2000 | EP1019052A1 Alpha 1a adrenergic receptor antagonists |
07/19/2000 | EP1019046A1 Protease inhibitors |
07/19/2000 | EP1019040A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS |
07/19/2000 | EP0821682B1 Benzimidazole compounds and their use as modulators of the gaba-a receptor complex |